Revisiting and Rebuilding Clinical Development of Drugs for Antimicrobial Resistance – Lessons Learned During the COVID Pandemic, Upcoming Webinar Hosted by Xtalks
Share Article
In this free webinar, the featured speakers will discuss the gravity and importance of antimicrobial resistance (AMR) clinical research and development, the potential impact of the COVID-19 pandemic and how we can turn the momentum into a positive for AMR research. They will also discuss the role of global AMR surveillance in clinical development.
In this webinar, we bring together AMR experts to discuss how we can use the momentum from the pandemic to rethink, rebuild and revitalize the pipeline for antibacterial drugs.